Pre-treatment dual immune checkpoint blockade in cervical cancer remains understudied. In this trial, the authors show that neoadjuvant immune checkpoint blockade enhances immune activation and correlates with improved response to subsequent chemoradiation in patients with cervical carcinoma.
- Isabelle Ray-Coquard
- Marie-Christine Kaminsky-Forrett
- Sarah Bétrian
